La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Joint Résultats passés
Passé contrôle des critères 0/6
Joint's earnings have been declining at an average annual rate of -41.6%, while the Healthcare industry saw earnings growing at 7.1% annually. Revenues have been growing at an average rate of 21.7% per year.
Informations clés
-41.6%
Taux de croissance des bénéfices
-41.4%
Taux de croissance du BPA
Healthcare Croissance de l'industrie | 8.5% |
Taux de croissance des recettes | 21.7% |
Rendement des fonds propres | -62.1% |
Marge nette | -12.0% |
Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Recent updates
The Joint Corp. (NASDAQ:JYNT) Shares Could Be 22% Above Their Intrinsic Value Estimate
Aug 05Investors Could Be Concerned With Joint's (NASDAQ:JYNT) Returns On Capital
Jul 17Optimistic Investors Push The Joint Corp. (NASDAQ:JYNT) Shares Up 26% But Growth Is Lacking
May 04The Joint Corp.'s (NASDAQ:JYNT) Share Price Not Quite Adding Up
Mar 10Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)
Feb 12Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue
Jun 17Joint's (NASDAQ:JYNT) Returns On Capital Are Heading Higher
Jan 04Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?
Oct 27The Joint Corp. Can Relieve You From High Inflation Pain
Oct 17The Joint Corp.: Weakening Bottom-Line Fundamentals Unsupportive In Current Landscape
Aug 05These 4 Measures Indicate That Joint (NASDAQ:JYNT) Is Using Debt Reasonably Well
Jul 22Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)
Jun 29Is There Now An Opportunity In The Joint Corp. (NASDAQ:JYNT)?
Jun 14Joint's (NASDAQ:JYNT) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Mar 03Should You Be Adding Joint (NASDAQ:JYNT) To Your Watchlist Today?
Feb 23Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?
Feb 08Joint Corp.: Solid Q4 Results From This Small-Cap Growth Story
Jan 30Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue
Jan 24What Does The Joint Corp.'s (NASDAQ:JYNT) Share Price Indicate?
Jan 08Do Joint's (NASDAQ:JYNT) Earnings Warrant Your Attention?
Nov 23Is Joint (NASDAQ:JYNT) A Risky Investment?
Nov 08Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue
Oct 21Is The Joint Corp. (NASDAQ:JYNT) Potentially Undervalued?
Oct 05The Joint Corporation: Time To Take Some Profits
Aug 10Is Joint (NASDAQ:JYNT) Using Too Much Debt?
Aug 02The Joint Corp. Has Rallied By 400% Since We Bought, But It's Time To Let It Go
Jul 23Ventilation des recettes et des dépenses
Comment Joint gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
30 Jun 24 | 120 | -14 | 101 | 0 |
31 Mar 24 | 119 | -11 | 98 | 0 |
31 Dec 23 | 118 | -10 | 98 | 0 |
30 Sep 23 | 115 | 2 | 95 | 0 |
30 Jun 23 | 112 | 4 | 92 | 0 |
31 Mar 23 | 107 | 3 | 90 | 0 |
31 Dec 22 | 101 | 1 | 84 | 0 |
30 Sep 22 | 95 | 0 | 82 | 0 |
30 Jun 22 | 89 | 2 | 76 | 0 |
31 Mar 22 | 85 | 5 | 69 | 0 |
31 Dec 21 | 80 | 8 | 62 | 0 |
30 Sep 21 | 76 | 18 | 55 | 0 |
30 Jun 21 | 70 | 17 | 50 | 0 |
31 Mar 21 | 63 | 15 | 46 | 0 |
31 Dec 20 | 59 | 13 | 44 | 0 |
30 Sep 20 | 56 | 4 | 43 | 0 |
30 Jun 20 | 53 | 3 | 41 | 0 |
31 Mar 20 | 51 | 3 | 40 | 0 |
31 Dec 19 | 48 | 3 | 37 | 0 |
30 Sep 19 | 45 | 2 | 35 | 0 |
30 Jun 19 | 41 | 2 | 33 | 0 |
31 Mar 19 | 39 | 1 | 31 | 0 |
31 Dec 18 | 37 | 0 | 30 | 0 |
30 Sep 18 | 34 | -1 | 28 | 0 |
30 Jun 18 | 31 | -1 | 26 | 0 |
31 Mar 18 | 28 | -2 | 24 | 0 |
31 Dec 17 | 25 | -3 | 23 | 0 |
30 Sep 17 | 24 | -9 | 23 | 0 |
30 Jun 17 | 23 | -11 | 25 | 0 |
31 Mar 17 | 22 | -13 | 26 | 0 |
31 Dec 16 | 21 | -15 | 26 | 0 |
30 Sep 16 | 19 | -13 | 26 | 0 |
30 Jun 16 | 17 | -12 | 24 | 0 |
31 Mar 16 | 16 | -10 | 21 | 0 |
31 Dec 15 | 14 | -9 | 19 | 0 |
30 Sep 15 | 12 | -8 | 15 | 0 |
30 Jun 15 | 10 | -7 | 12 | 0 |
31 Mar 15 | 8 | -5 | 9 | 0 |
31 Dec 14 | 7 | -3 | 6 | 0 |
30 Sep 14 | 7 | 0 | 5 | 0 |
30 Jun 14 | 6 | 0 | 4 | 0 |
31 Mar 14 | 6 | 0 | 4 | 0 |
31 Dec 13 | 6 | 0 | 3 | 0 |
Des revenus de qualité: JYNT is currently unprofitable.
Augmentation de la marge bénéficiaire: JYNT is currently unprofitable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: JYNT is unprofitable, and losses have increased over the past 5 years at a rate of 41.6% per year.
Accélération de la croissance: Unable to compare JYNT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Bénéfices par rapport au secteur d'activité: JYNT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (6%).
Rendement des fonds propres
ROE élevé: JYNT has a negative Return on Equity (-62.07%), as it is currently unprofitable.